Meinolf Wonnemann - Concepedia

Author

Meinolf Wonnemann

Goethe University Frankfurt ORCID

Also Known As

M Wonnemann, M. Wonnemann, Meinolf Wonnemann, Wonnemann, M

Publications

1.7K

Citations

H-Index

Concepts

All Affiliations

Goethe University Frankfurt SocraTec R&D (Germany)Bayer (Germany)Bionorica (Germany)Frankfurt University of Applied Sciences

About

Meinolf Wonnemann is an author at Goethe University Frankfurt specializing in medicine, pharmacology, and nutrition.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	922
2	Health Sciences	2	2	86
3	Public Health	1	1	22
4	Social Sciences	1	1	121
5	Biochemistry	1	1	118

Meinolf Wonnemann

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Hyperforin as a possible antidepressant component of hypericum extracts S. S. Chatterjee, S.K. Bhattacharya, Meinolf Wonnemann, Life Sciences MedicineHerbal MedicineHerb-drug InteractionNeuropharmacologyPhytopharmacology	1998	444
Hyperforin Represents the Neurotransmitter Reuptake Inhibiting Constituent of Hypericum Extract Wernér E.G. Müller, A. Singer, Meinolf Wonnemann, Pharmacopsychiatry	1998	266
Hyperforin, a Major Antidepressant Constituent of St. John’s Wort, Inhibits Serotonin Uptake by Elevating Free Intracellular Na+1 1 A. Singer, Meinolf Wonnemann, Wernér E.G. Müller Journal of Pharmacology and Experimental Therapeutics	1999	239
Hyperforin - Antidepressant Activity by a Novel Mechanism of Action Wernér E.G. Müller, A. Singer, Meinolf Wonnemann Pharmacopsychiatry PsychopharmacologyMany Other AntidepressantsAntidepressant ActivityPharmacotherapySocial Sciences	2001	121
Inhibition of Synaptosomal Uptake of 3H-L-glutamate and 3H-GABA by Hyperforin, a Major Constituent of St. John's Wort The Role of Amiloride Sensitive Sodium Conductive Pathways Meinolf Wonnemann Neuropsychopharmacology BiochemistryNeurophysiologyMedicinePhysiologyNeurotransmitter	2000	118
Evaluation of Synaptosomal Uptake Inhibition of most Relevant Constituents of St. John's Wort Meinolf Wonnemann, A. Singer, B. Siebert, Pharmacopsychiatry	2001	68
Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union Barbara Schug, E. Brendel, Dörte Wolf, European Journal of Pharmaceutical Sciences NutritionFood AdditiveFood AnalysisFormulation-dependent Food EffectsNifedipine Modified-release Preparations	2002	66
Influence of pharmaceutical quality on the bioavailability of active components from <i>Ginkgo biloba</i> preparations S. Kressmann, A. Biber, Meinolf Wonnemann, Journal of Pharmacy and Pharmacology Food ChemistryMedicinal ChemistryActive ComponentsGinkgolide BGinkgo Biloba Capsules	2002	62
Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfast Barbara Schug, E. Brendel, Meinolf Wonnemann, European Journal of Clinical Pharmacology NutritionMedicinePublic Health NutritionMedical Nutrition TherapyPharmacology	2002	50
Assessment of efficacy and safety of the herbal medicinal product BNO 1016 in chronic rhinosinusitis Jürgen Palm, Ilse Steiner, Dimitri Abramov-Sommariva, Rhinology Journal	2017	30

Page 1